Located far away from regulators, many of these pharmaceutical factories lack proper oversight, writes Katherine Eban in Bottle of Lies: The Inside Story of the Generic Drug Boom. Eban’s investigation revealed multiple examples of forged paperwork that concealed manufacturing shortcuts and sanitary violations, resulting in contaminated or ineffective drugs.

